These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38561602)
1. Integrated care van delivery of evidence-based services for people who inject drugs: A cluster-randomized trial. Page KR; Weir BW; Zook K; Rosecrans A; Harris R; Grieb SM; Falade-Nwulia O; Landry M; Escobar W; Ramirez MP; Saxton RE; Clarke WA; Sherman SG; Lucas GM Addiction; 2024 Jul; 119(7):1276-1288. PubMed ID: 38561602 [TBL] [Abstract][Full Text] [Related]
2. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial. Solomon SS; Quinn TC; Solomon S; McFall AM; Srikrishnan AK; Verma V; Kumar MS; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Thomas DL; Sachdeva KS; Lucas GM; Mehta SH J Hepatol; 2020 Jan; 72(1):67-74. PubMed ID: 31604081 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339 [TBL] [Abstract][Full Text] [Related]
5. Mobile low-threshold buprenorphine integrated with infectious disease services. Rosecrans A; Harris R; Saxton RE; Cotterell M; Zoltick M; Willman C; Blackwell I; Bell J; Hayes D; Weir B; Sherman S; Lucas GM; Greenbaum A; Page KR J Subst Abuse Treat; 2022 Feb; 133():108553. PubMed ID: 34238629 [TBL] [Abstract][Full Text] [Related]
7. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India. Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077 [TBL] [Abstract][Full Text] [Related]
8. Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs. Tookes HE; Oxner A; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; McCollister K; Rodriguez A; Kolber MA; Chueng TA; Zayas S; McCoy B; Sutherland K; Archer C; Bartholomew TS Trials; 2023 Feb; 24(1):96. PubMed ID: 36750867 [TBL] [Abstract][Full Text] [Related]
9. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada. Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB; Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989 [TBL] [Abstract][Full Text] [Related]
10. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey. Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139 [TBL] [Abstract][Full Text] [Related]
11. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services. Bartholomew TS; Plesons M; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; Chueng TA; Ciraldo K; Brooks J; Smith JD; Barocas JA; Tookes HE Addict Sci Clin Pract; 2024 Mar; 19(1):21. PubMed ID: 38528570 [TBL] [Abstract][Full Text] [Related]
12. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. Auriacombe M; Roux P; Briand Madrid L; Kirchherr S; Kervran C; Chauvin C; Gutowski M; Denis C; Carrieri MP; Lalanne L; Jauffret-Roustide M; BMJ Open; 2019 Feb; 9(2):e023683. PubMed ID: 30796121 [TBL] [Abstract][Full Text] [Related]
13. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia. Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120 [TBL] [Abstract][Full Text] [Related]
14. Design of the Indian NCA study (Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of integrated care centers to improve HIV outcomes among men who have sex with men and persons who inject drugs in India. Solomon SS; Lucas GM; Celentano DD; McFall AM; Ogburn E; Moulton LH; Srikrishnan AK; Kumar MS; Anand S; Solomon S; Mehta SH BMC Health Serv Res; 2016 Nov; 16(1):652. PubMed ID: 27842543 [TBL] [Abstract][Full Text] [Related]
15. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state. Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523 [TBL] [Abstract][Full Text] [Related]
16. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda. Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940 [TBL] [Abstract][Full Text] [Related]
17. Network centrality and HIV prevention service use among people who inject drugs: Findings from a sociometric network cohort in New Delhi, India. Prata Menezes N; Mehta SH; Wesolowski A; Clipman SJ; Srikrishnan AK; Kumar MS; Zook KJC; Lucas GM; Latkin C; Solomon SS Addiction; 2024 Mar; 119(3):570-581. PubMed ID: 37967827 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials. van Santen DK; Lodi S; Dietze P; van den Boom W; Hayashi K; Dong H; Cui Z; Maher L; Hickman M; Boyd A; Prins M Addiction; 2023 Jun; 118(6):1116-1126. PubMed ID: 36710474 [TBL] [Abstract][Full Text] [Related]
19. Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study). Goodman-Meza D; Shoptaw S; Hanscom B; Smith LR; Andrew P; Kuo I; Lake JE; Metzger D; Morrison EAB; Cummings M; Fogel JM; Richardson P; Harris J; Heitner J; Stansfield S; El-Bassel N; Trials; 2024 Feb; 25(1):124. PubMed ID: 38360750 [TBL] [Abstract][Full Text] [Related]
20. Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study. Roux P; Rojas Castro D; Ndiaye K; Debrus M; Protopopescu C; Le Gall JM; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri P PLoS One; 2016; 11(6):e0157062. PubMed ID: 27294271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]